Who founded Purespring?

Purespring was founded by Moin Saleem in 2020.

Who are Purespring's investors?

Purespring's investors include Sofinnova Partners, Forbion, Gilde Healthcare, Syncona, Advent Life Sciences, British Patient Capital.

Purespring

Founded 2020 · 58 employees on LinkedIn · 7 known investors

Find your way into Purespring

Paths you didn't know you had: your email and LinkedIn already hold routes to the Purespring team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Purespring develops genetic therapies targeting podocytes to treat renal diseases through its proprietary GlomThera platform. The company focuses on preserving kidney function in patients with large, underserved populations affected by renal disease.

Biotech Digital Health Healthtech Medical Devices

Founders & leadership

Purespring was founded in 2020 by Moin Saleem.

Moin SaleemCo-founder & Chief Scientific Advisor

Investors · 7

Sofinnova Partners✓ confirmed by PurespringParis · $540K – $27M

How we know: Sofinnova Partners's portfolio page · the company's own site · a partner's Signal profile · funding news · press coverage · Not right? Tell us

Forbion✓ confirmed by PurespringNaarden

How we know: the company's own site · funding news · sharecast.com · open dataset · 5k.vc investor directory · Not right? Tell us

Gilde Healthcare✓ confirmed by PurespringUtrecht · $1.1M – $55M

How we know: the company's own site · funding news · sharecast.com · Not right? Tell us

Synconalisted by SynconaLondon

How we know: Syncona's portfolio page · sharecast.com · open dataset · 5k.vc investor directory · Not right? Tell us

Advent Life SciencesreportedLondon

How we know: a partner's Signal profile · Not right? Tell us

British Patient CapitalreportedLondon

How we know: funding news · sharecast.com · Not right? Tell us

Also in the syndicate · 1

Sofinnovalead

In the news

News - Purespring Therapeuticspurespringtx.com · Oct 2025

Purespring Therapeutics raises £80M to develop gene therapies aimed at kidney diseases — TFNtechfundingnews.com · Oct 2024

Purespring Therapeutics Raises $105M in Series B Financingfinsmes.com · Oct 2024

Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases - Purespring Therapeuticspurespringtx.com · Oct 2024

Frequently asked questions

What does Purespring do?: Purespring develops genetic therapies targeting podocytes to treat renal diseases through its proprietary GlomThera platform. The company focuses on preserving kidney function in patients with large, underserved populations affected by renal disease.
Who founded Purespring?: Purespring was founded by Moin Saleem in 2020.
Who are Purespring's investors?: Purespring's investors include Sofinnova Partners, Forbion, Gilde Healthcare, Syncona, Advent Life Sciences, British Patient Capital.